Search
for

    Sort by

    Research 91–120 of 1000+

    1. Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman Annals of internal medicine · 1978 · 39 citations
    2. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis Clinical Interventions in Aging · 2019 · 38 citations
    3. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome Urology · 2018 · 35 citations
    4. Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review Sexual medicine reviews · 2013 · 35 citations
    5. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. PubMed · 2016 · 32 citations
    6. Finasteride Treatment of Hair Loss in Women Annals of Pharmacotherapy · 2010 · 29 citations
    7. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review Dermatology Online Journal · 2017 · 21 citations
    8. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    9. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia Annals of Dermatology · 2016 · 19 citations
    10. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis Acta dermato-venereologica · 2018 · 15 citations
    11. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    12. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men’s Health Current Urology Reports · 2018 · 13 citations
    13. Sexual dysfunction in men taking systemic dermatologic medication: A systematic review Journal of The American Academy of Dermatology · 2019 · 11 citations
    14. Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function Current Urology Reports · 2014 · 11 citations
    15. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors Sexual medicine reviews · 2018 · 10 citations
    16. ‘Post-finasteride syndrome’: what to tell our female patients? British Journal of Dermatology · 2018 · 4 citations
    17. The post-finasteride syndrome: possible etiological mechanisms and symptoms International journal of impotence research · 2023 · 3 citations
    18. Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men. PubMed · 2015 · 3 citations
    19. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    20. Topical Minoxidil 5% Induced Male Sexual Dysfunction Zenodo (CERN European Organization for Nuclear Research) · 2017 · 2 citations
    21. Male Sex Hormones in Andrology Today Springer eBooks · 2022 · 1 citations
    22. Pharmacological benefits of plant extract of Peperomia pellucida growing wild in Suburb of Bandar Lampung, Indonesia Zenodo (CERN European Organization for Nuclear Research) · 2022 · 1 citations
    23. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Actas Dermo-Sifiliográficas · 2016 · 1 citations
    24. Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis Journal of The American Academy of Dermatology · 2015 · 1 citations
    25. Getting to grips with hair loss Inpharma Weekly · 1997 · 1 citations
    26. DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS Asclepius International Journal of Scientific Health Science · 2026
    27. Unexpected Hair Regrowth Following Oral Bicalutamide Exposure in a Male Patient With Androgenetic Alopecia and a Suboptimal Response to Conventional Therapies: A Case Report Cureus · 2026
    28. Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review Frontiers in Medicine · 2026
    29. Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety Cureus · 2026
    30. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026